Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
2,292
Showing 50 of 2,292
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CERO | Cero Therapeutics Holdings, Inc. | 29 | 5 | 100% | +94.6% | +94.7% | +96.3% | +90.5% |
| 2 | MULN | Mullen Automotive Inc. | 20/32 | 10 | 100% | +94.4% | +99.3% | +100.0% | +78.5% |
| 3 | IONM | Assure Holdings Corp. | 29 | 3 | 100% | +89.1% | +88.1% | +93.3% | +82.8% |
| 4 | CTNT | Cheetah Net Supply Chain Service Inc. | 11 | 6 | 100% | +88.6% | +89.5% | +98.8% | +73.0% |
| 5 | EVLO | Evelo Biosciences, Inc. | 18 | 5 | 100% | +87.6% | +86.0% | +99.6% | +60.4% |
| 6 | ZSPC | Zspace, Inc. | 18/30 | 5 | 100% | +83.8% | +81.9% | +90.9% | +80.7% |
| 7 | MICS | Singing MacHine Co Inc | 26/29 | 6 | 100% | +83.5% | +97.8% | +98.6% | +4.0% |
| 8 | TTOO | T2 Biosystems, Inc. | 171 | 11 | 100% | +83.2% | +86.4% | +94.8% | +14.9% |
| 9 | PRST | Presto Automation Inc. | 29 | 7 | 97% | +82.4% | +90.1% | +98.7% | -4.5% |
| 10 | LYRA | Lyra Therapeutics, Inc. | 50/52 | 6 | 100% | +82.0% | +82.6% | +85.1% | +62.9% |
| 11 | CDT | Conduit Pharmaceuticals Inc. | 54 | 7 | 100% | +81.5% | +86.9% | +93.5% | +61.3% |
| 12 | BURU | Nuburu, Inc. | 650 | 10 | 100% | +77.3% | +78.0% | +80.0% | +74.2% |
| 13 | PXMD | Paxmedica, Inc. | 50 | 5 | 100% | +76.9% | +74.7% | +93.9% | +48.4% |
| 14 | BTAI | Bioxcel Therapeutics, Inc. | 74/78 | 9 | 100% | +75.8% | +77.7% | +86.5% | +49.6% |
| 15 | EFTR | Effector Therapeutics, Inc. | 102 | 11 | 100% | +75.7% | +74.5% | +87.8% | +68.0% |
| 16 | VLD | Velo3d, Inc. | 87/127 | 8 | 98% | +75.6% | +77.0% | +97.8% | -19.9% |
| 17 | FXLV | F45 Training Holdings Inc. | 32 | 3 | 100% | +74.7% | +75.7% | +81.2% | +65.8% |
| 18 | AZTR | Azitra Inc | 54 | 18 | 100% | +74.7% | +74.7% | +74.7% | +74.7% |
| 19 | IBIO | Ibio, Inc. | 17 | 3 | 100% | +73.6% | +77.1% | +90.1% | +25.7% |
| 20 | VIA | Via Transportation, Inc. | 12 | 4 | 100% | +72.1% | +72.1% | +72.1% | +72.1% |
| 21 | MGNX | MacRogenics Inc | 19 | 6 | 100% | +72.1% | +80.7% | +84.7% | +2.4% |
| 22 | ASST | Asset Entities Inc. | 24 | 8 | 100% | +70.9% | +68.9% | +86.4% | +57.7% |
| 23 | MYSZ | My Size, Inc. | 14 | 5 | 100% | +69.9% | +72.3% | +77.8% | +36.0% |
| 24 | RELI | Reliance Global Group, Inc. | 16/17 | 5 | 100% | +69.3% | +78.6% | +84.8% | +10.1% |
| 25 | SSNT | Silversun Technologies, Inc. | 48/54 | 10 | 100% | +67.9% | +88.8% | +93.1% | +9.1% |
| 26 | EONR | Eon Resources Inc. | 15 | 5 | 100% | +67.4% | +64.7% | +74.2% | +63.4% |
| 27 | PEPG | Pepgen Inc. | 24/31 | 8 | 100% | +67.3% | +70.0% | +88.5% | +14.4% |
| 28 | BNZI | Banzai International, Inc. | 31 | 3 | 100% | +66.8% | +64.6% | +84.4% | +58.6% |
| 29 | BSLK | Bolt Projects Holdings, Inc. | 19 | 3 | 95% | +66.7% | +67.2% | +97.9% | -8.5% |
| 30 | DRCT | Direct Digital Holdings, Inc. | 89 | 5 | 100% | +66.7% | +65.2% | +94.9% | +8.9% |
| 31 | AGBA | Agba Group Holding Ltd. | 22 | 3 | 100% | +65.9% | +69.2% | +82.2% | +41.1% |
| 32 | KITT | Nauticus Robotics, Inc. | 16/17 | 7 | 100% | +65.8% | +75.0% | +84.9% | +4.0% |
| 33 | GRPH | Graphite Bio, Inc. | 308 | 10 | 100% | +65.8% | +69.2% | +82.2% | +4.9% |
| 34 | MIRA | Mira Pharmaceuticals, Inc. | 48 | 3 | 98% | +65.1% | +76.2% | +81.7% | -4.3% |
| 35 | TPHS | Trinity Place Holdings Inc. | 21 | 3 | 100% | +64.8% | +64.1% | +81.5% | +24.4% |
| 36 | MRAI | Marpai, Inc. | 39 | 5 | 97% | +64.7% | +71.4% | +83.0% | -129.2% |
| 37 | SKYE | Skye Bioscience, Inc. | 100 | 13 | 100% | +64.4% | +60.0% | +79.2% | +52.9% |
| 38 | CYCC | Cyclacel Pharmaceuticals, Inc. | 22 | 5 | 100% | +64.3% | +66.3% | +90.2% | +35.9% |
| 39 | MNTS | Momentus Inc. | 491 | 8 | 100% | +64.2% | +77.9% | +96.2% | +12.7% |
| 40 | LIFW | Msp Recovery, Inc. | 70/72 | 7 | 97% | +63.5% | +67.6% | +83.5% | -14.7% |
| 41 | GTII | Global Tech Industries Group, Inc. | 78 | 4 | 100% | +63.3% | +67.9% | +97.5% | +13.7% |
| 42 | ANTX | An2 Therapeutics, Inc. | 129/139 | 20 | 89% | +62.9% | +80.2% | +89.3% | -325.4% |
| 43 | VERO | Venus Concept Inc. | 77 | 9 | 100% | +62.3% | +65.2% | +70.0% | +30.7% |
| 44 | SDOT | Sadot Group Inc. | 13/15 | 5 | 100% | +62.2% | +67.7% | +90.1% | +27.1% |
| 45 | NMRA | Neumora Therapeutics, Inc. | 17/21 | 6 | 100% | +61.7% | +85.4% | +96.2% | +5.2% |
| 46 | SONX | Sonendo, Inc. | 60 | 9 | 97% | +61.1% | +68.1% | +94.9% | -61.4% |
| 47 | FWBI | First Wave Biopharma, Inc. | 10/18 | 3 | 90% | +60.7% | +72.6% | +91.9% | -16.7% |
| 48 | NOTV | Inotiv, Inc. | 18/22 | 8 | 100% | +60.6% | +52.1% | +83.4% | +41.5% |
| 49 | FIG | Figma, Inc. | 107/181 | 24 | 100% | +60.1% | +75.4% | +75.4% | +25.3% |
| 50 | LUCY | Innovative Eyewear Inc | 49/64 | 3 | 100% | +59.4% | +54.9% | +68.1% | +35.4% |
Showing 1-50 of 2,292